Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Data & Figures
Ordering
Resources
Publications
hTERT ICC Test
Pipeline
Development Pipeline
SubB2M CA15-3
SubB2M CA125
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
Conferences & Events
Media
INOVIQ in the News
Contact
Contact Us
Subscribe to Email Alerts
Analyst Reports
Heading &
Sub-heading can be edited through HQI
Investors
>
Analyst Reports
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
Conferences & Events
Analyst Reports
Filter by Year:
2023
2022
7-Sep-2023
EXO-NET agreement with CDO to grow US revenue opportunity
7-Jul-2023
Global Joint Marketing Agreement: Major Boost to EXO-NET® Profile
28-Jun-2023
SubB2M/CA15-3 Test: Striking Study Results in Breast Cancer
13-Feb-2023
Good signs of progress in 2Q, SubB2M breast cancer study data
1
